XML 33 R7.htm IDEA: XBRL DOCUMENT v3.24.0.1
Consolidated Statements of Equity - USD ($)
shares in Thousands, $ in Thousands
Total
Total Itron, Inc. Shareholders' Equity
Common Stock
Common Stock
Accumulated Other Comprehensive Income (Loss)
Accumulated Deficit
Noncontrolling Interests
Balance (in shares) at Dec. 31, 2020     40,444        
Balance (value) at Dec. 31, 2020 $ 840,273 $ 816,548   $ 1,389,419 $ (138,526) $ (434,345) $ 23,725
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Net income (loss) (78,298) (81,255)       (81,255) 2,957
Other comprehensive income (loss), net of tax (9,572) (9,572)     (9,572)   0
Options exercised (in shares)     30        
Options exercised (value) 1,924 1,924   1,924      
Restricted stock awards released (in shares)     285        
Restricted stock awards released (value) (804) (804)   (804)      
Issuance of stock-based compensation awards (in shares)     9        
Issuance of stock-based compensation awards (value) 856 856   856      
Employee stock purchase plan (in shares)     37        
Employee stock purchase plan (value) 3,156 3,156   3,156      
Stock-based compensation expense 22,762 22,762   22,762      
Stock issued related to equity offering (in shares)     4,472        
Stock issued related to equity offering 389,419 389,419   389,419      
Proceeds from sale of warrants 45,349 45,349   45,349      
Purchases of convertible note hedge contracts, net of tax (63,576) (63,576)   (63,576)      
Registration fee (359) (359)   (359)      
Stock repurchased during period, shares     (125)        
Stock Repurchased During Period, Value (8,028) (8,028)   (8,028)      
Stockholders' Equity, Other (343) (343)   (343)      
Balance (in shares) at Dec. 31, 2021     45,152        
Balance (value) at Dec. 31, 2021 1,142,759 1,116,077   1,779,775 (148,098) (515,600) 26,682
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Net income (loss) (9,547) (9,732)       (9,732) 185
Other comprehensive income (loss), net of tax 53,424 53,424     53,424   0
Distributions to noncontrolling interests (3,784) 0         (3,784)
Options exercised (in shares)     1        
Options exercised (value) 30 30   30      
Restricted stock awards released (in shares)     227        
Restricted stock awards released (value) 0 0   0      
Issuance of stock-based compensation awards (in shares)     16        
Issuance of stock-based compensation awards (value) 952 952   952      
Employee stock purchase plan (in shares)     70        
Employee stock purchase plan (value) 3,422 3,422   3,422      
Stock-based compensation expense 20,929 20,929   20,929      
Proceeds from sale of warrants 0            
Stock repurchased during period, shares     (280)        
Stock Repurchased During Period, Value $ (16,629) (16,629)   (16,629)      
Balance (in shares) at Dec. 31, 2022 45,186   45,186        
Balance (value) at Dec. 31, 2022 $ 1,191,556 1,168,473   1,788,479 (94,674) (525,332) 23,083
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Net income (loss) 98,318 96,923       96,923 1,395
Other comprehensive income (loss), net of tax 13,484 13,484     13,484   0
Distributions to noncontrolling interests (3,958) 0         (3,958)
Options exercised (in shares)     18        
Options exercised (value) 830 830   830      
Restricted stock awards released (in shares)     242        
Restricted stock awards released (value) 0 0   0      
Issuance of stock-based compensation awards (in shares)     15        
Issuance of stock-based compensation awards (value) 1,065 1,065   1,065      
Employee stock purchase plan (in shares)     51        
Employee stock purchase plan (value) 2,844 2,844   2,844      
Stock-based compensation expense 27,292 27,292   27,292      
Proceeds from sale of warrants $ 0            
Balance (in shares) at Dec. 31, 2023 45,512   45,512        
Balance (value) at Dec. 31, 2023 $ 1,331,431 $ 1,310,911   $ 1,820,510 $ (81,190) $ (428,409) $ 20,520